3Vote!
thepharmaletter.com (Free subscription) | 4 hours ago
As the pharmaceutical industry hurtles ever closer towards the ‘patent cliff,’ Big Pharma is busy implementing strategies to lessen the impact of the loss of patent protection on some of the industry’s biggest sellers on their collective bottom lines. In an effort to mitigate the impact, Big Pharma is seemingly investing as much time and energy into diversification as R&D. However,...
3Vote!
Radon Mitigation Pittsburgh (Free subscription) | yesterday
November 23, 2009 (FinancialWire) Becton, Dickinson and Co. (NYSE: BDX) has closed its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. In May 2009, BD and HandyLab announced an exclusive agreement for BD to develop and commercialize molecular assays on the HandyLab Jaguar platform, an integrated...
3Vote!
New York Supreme Court Criminal Ter (Free subscription) | yesterday
Source: Lexology, November 23, 2009. DOJ cautions pharmaceutical companies on increased FCPA enforcement Hogan & Hartson LLP "In the months and years ahead the Department of Justice (DOJ) will continue to focus on the pharmaceutical industry in its criminal enforcement of the Foreign Corrupt Practices Act (FCPA), according to the head of the DOJ's Criminal Division."
3Vote!
PharmaGossip (Free subscription) | yesterday
Pharmaceutical industry spokesmen must use Botox. How else could they keep a straight face while explaining that their employers raised prices by an average of 9 percent this year, the biggest single increase in nearly two decades, because they need to invest in the research and development of new drugs? Earlier this year, credit card holders started receiving letters announcing huge increases in...
3Vote!
Postingan Lowongan Kerja (Free subscription) | 22/11/2009
------Original Message------ From: dwimadia Sender: Head-Hunter@yahoogroups.com To: Head-Hunter@yahoogroups.com Subject: [Head-Hunter] Big Opportunities in PT.Combiphar Sent: Nov 15, 2009 23:31 PT.COMBIPHAR, an aggressive pharmaceutical company are seeking high caliber & result-oriented individual to fill the position as : 1.INTERNAL AUDITOR (IA) Requirements : •Male / Female with maximum...
3Vote!
Pharm Aid (Free subscription) | 21/11/2009
I’ve been surprised by a number of people that I generally respect in the medical world that have embraced the USPSTF recommendations against breast cancer screening with gusto. Some of these same individuals would pour over a pharmaceutical industry funded study to pick it apart. When it comes to the USPSTF recommendations, they’re willing to blindly accept the results – without...
3Vote!
PharmaGossip (Free subscription) | 21/11/2009
IN MAKING a fool of President Obama, Big Pharma has turned itself into a poison pill of health care reform. In the summer, the drug companies offered $8 billion a year over 10 years in drug cost cuts, as long as the government did not ask for further reductions in what Medicare provides them. Obama proclaimed this a huge breakthrough, given the drug industry’s prior attacks on reform. “The...
3Vote!
Count Us Out (Free subscription) | 21/11/2009
Information: The newly-forged 1990-page “Affordable Health Care for America Act” (HR 3962) offered by the House of Representatives is filled with mental health provisions intended to prop up psychiatry as well as the pharmaceutical industry with billions in future income. Key mental health components of this House bill: MOTHERS Act The bill includes the language of the [...]
3Vote!
PharmaGossip (Free subscription) | 21/11/2009
Is the support of the pharmaceutical industry needed for Congress to pass health care reform? Or is the price of that support too high for the people the reform package is trying to help? Those questions took on new urgency this week with the release of a study by AARP, the seniors advocacy group, that found that drug makers had raised the wholesale price of brand-name prescription drugs by 9 percent,...
3Vote!
SBWire Press Releases (Free subscription) | 21/11/2009
Deacom, Inc. today announced Supplemental Manufacturing and Ingredients, LLC ("SMI"), a manufacturer of dietary and nutritional supplements based in Tempe, Ariz. and the exclusive manufacturer of products for HealthSport, Inc. (OTCBB:HSPO), has licensed the DEACOM Integrated Accounting and Enterprise Resource Planning (ERP) Software System to facilitate the company's entrance into the pharmaceutical...
5Vote!
Connecting the Dots in the New World Order (Free subscription) | 21/11/2009
The head of the Health Net of Alzey und Framersheimer, GP Dr Friedel Rohr, has accused the German Health Ministry of deceiving the general public about the risks associated with the swine flu jab. In a report in the local newspaper, Allgemine Zeitung, Alzey, Rohr said that there had been "massive lies" on the part of the German government concerning the jab and the adjuvant squalene. He said...
4Vote!
Medical News Today (Free subscription) | 21/11/2009
Drug approvals are taking just as long as they ever did despite increased expenditure on new information technology at the Food and drug Administration. So says a statistical analysis of approval intervals from 1997 to 2006, published in the International Journal of Electronic Healthcare.
3Vote!
Mouth of the Potomac (Free subscription) | 20/11/2009
With all the pressure to find savings in health care, it’s quite a testament to the pharmaceutical industry lobbyists that they’ve managed to keep some $71 billion protected in the Senate measure. You see, that’s because under the section entitled “Improving Access to Innovative Medical Therapies,” the bill would grant makers of the growing class of drugs known as biologics...
3Vote!
Later On (Free subscription) | 20/11/2009
Never: Source: Think Progress, November 18, 2009 The pharmaceutical industry-funded front group Center for Medicine in the Public Interest(CMPI) is helping its corporate funders fight health care reform by disseminating misinformation and orchestrating campaigns to generate fear about health care reform. CMPI arose out of the Pacific Research Institute, a corporate front group that worked with Philip...
3Vote!
racine housing (Free subscription) | 20/11/2009
This October saw yet another medical device fail in a high-profile clinical trial. Alongside the pharmaceutical industry, manufacturers have been designing devices to help people lose weight. Why? Well, with obesity reaching epidemic proportions around the world, there are millions of people "out there" waiting to buy something that will help them shed unwanted pounds. [...]
Videos